Amgen Inc Stock Forecast for 2023 - 2025 - 2030

Updated on 01/31/2023

Stock Rating
7
Price Target
$278.00
Consensus
Neutral
Upside
2.31%
Analysts
0
Stock Rating
7
Upside
2.31%
Analysts
0
Price Target
$278.00

Amgen Inc Stock Forecast and Price Target

Amgen Inc's most recent price target of $278.00 for 2023 was provided by renowned analysts over the past few months, with an average prediction of $278.00. If this prediction is correct, Amgen Inc's stock could rise by 2.31 percent from its current trading price. The potential increase for the stock is $278.00 per share, with a possible range of $180.00 to $325.00. If you are interested in AMGN stock, you should also look at its competitors.

$278.00

2.31% Upside

Hold
Hold

Amgen Inc Fair Value Forecast for 2023 - 2025 - 2030

In the last zero years, Amgen Inc's Price has fallen from $155.10 to $155.10 – a 0.00% decrease. In the next year, analysts expect Fair Value to reach $288.75 – an increase of 86.17%. For the next eight years, the forecast is for Fair Value to grow by 133.37%.

2023 Fair Value Forecast
$288.75
2024 Fair Value Forecast
$317.70
2025 Fair Value Forecast
$326.10
2026 Fair Value Forecast
$339.15
2027 Fair Value Forecast
$352.95
2028 Fair Value Forecast
$354.00
2029 Fair Value Forecast
$341.85
2030 Fair Value Forecast
$361.95
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ABBV Stock Forecast AbbVie Outperform 10
$147.74 $162.12 11.68%
NasdaqGS:ALXN Stock Forecast Alexion Pharmaceuticals - 15
$182.50 $177.38 29.40%
BMRN Stock Forecast BioMarin Pharmaceutical Outperform 10
$115.35 $115.45 4.03%
INCY Stock Forecast Incyte Outperform 9
$85.14 $88.18 1.01%
ARNA Stock Forecast Arena Pharmaceuticals - 6
$99.99 $95.80 11.05%

Amgen Inc Revenue Forecast for 2023 - 2025 - 2030

In the last zero years, Amgen Inc's Revenue has fallen from $25979.00T to $25979.00T – a 0.00% decrease. According to 24 prominent analysts, Amgen Inc's Revenue will fall by 100.00% in the next year, reaching $27.32B. By 2030, professionals believe that Amgen Inc's Revenue will decrease by 100.00%, reaching $28.05B – a concerning trend for the company.

2023 Rev Forecast
$27.32B
2024 Rev Forecast
$28.62B
2025 Rev Forecast
$28.96B
2026 Rev Forecast
$29.35B
2027 Rev Forecast
$29.95B
2028 Rev Forecast
$29.64B
2029 Rev Forecast
$28.43B
2030 Rev Forecast
$28.05B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
EXEL Stock Forecast Exelixis Outperform 16
$17.62 $26.06 41.88%
ARWR Stock Forecast Arrowhead Pharmaceuticals Outperform 7
$34.99 $73.38 114.35%
CCXI Stock Forecast ChemoCentryx Outperform 8
$51.99 $34.75 24.06%

Amgen Inc Dividend per Share Forecast for 2023 - 2025 - 2030

Amgen Inc's Dividend per Share has decreased In the last zero years, from $8.52 to $8.52 – a 0.00% drop. In the following year, 11 experts forecast Amgen Inc's Dividend per Share will decrease by 2.82%, to $8.28. Over the next eight years, experts anticipate that Amgen Inc's Dividend per Share will grow at a rate of 48.36%.

2023 DPS Forecast
$8.28
2024 DPS Forecast
$9.30
2025 DPS Forecast
$9.81
2026 DPS Forecast
$10.70
2027 DPS Forecast
$11.14
2028 DPS Forecast
$11.14
2029 DPS Forecast
$11.87
2030 DPS Forecast
$12.64
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
DRNA Stock Forecast Dicerna Pharmaceuticals - 7
$38.22 $39.67 10.83%
FOLD Stock Forecast Amicus Therapeutics Outperform 7
$13.04 $14.60 15.03%
BCRX Stock Forecast BioCryst Pharmaceuticals Outperform 7
$10.55 $17.08 23.22%

Amgen Inc Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last zero years, Amgen Inc's Free Cash Flow has gone down from $9031.00T to $9031.00T – a 0.00% drop. In the next year, 5 analysts estimate that Amgen Inc's Free Cash Flow will decrease by 100.00%, reaching $10.40B. According to professional forecasts, in 2030, Amgen Inc's Free Cash Flow will decrease by 100.00%, reaching $12.27B.

2023 FCF Forecast
$10.40B
2024 FCF Forecast
$11.22B
2025 FCF Forecast
$11.38B
2026 FCF Forecast
$11.92B
2027 FCF Forecast
$12.85B
2028 FCF Forecast
$12.95B
2029 FCF Forecast
$12.66B
2030 FCF Forecast
$12.27B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ACAD Stock Forecast ACADIA Pharmaceuticals Outperform 6
$19.03 $29.50 5.10%
BPMC Stock Forecast Blueprint Medicines Outperform 6
$46.70 $119.23 68.09%
SAGE Stock Forecast Sage Therapeutics Outperform 6
$44.34 $101.45 21.79%

Amgen Inc Net Income Forecast for 2023 - 2025 - 2030

In the last zero years, Amgen Inc's Net Income has seen a drop from $5893.00T to $5893.00T – a 0.00% decrease. According to 22 major analysts, Amgen Inc's Net Income will fall by 100.00% in the next year, reaching $10.25B. Professionals believe that By 2030, Amgen Inc's Net Income will fall to $9.85B– a 100.00% decrease from its current value.

2023 NI Forecast
$10.25B
2024 NI Forecast
$11.03B
2025 NI Forecast
$11.12B
2026 NI Forecast
$11.35B
2027 NI Forecast
$11.12B
2028 NI Forecast
$10.76B
2029 NI Forecast
$10.04B
2030 NI Forecast
$9.85B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
IOVA Stock Forecast Iovance Biotherapeutics Outperform 4
$7.95 $34.92 239.62%
FATE Stock Forecast Fate Therapeutics Outperform 7
$5.96 $109.67 1275.84%
DVAX Stock Forecast Dynavax Technologies Buy 11
$11.15 $22.67 137.67%

Amgen Inc EBITDA Forecast for 2023 - 2025 - 2030

In the last zero years, Amgen Inc's EBITDA has fallen from $12801.00T to $12801.00T – a 0.00% decrease. According to 6 analysts, Amgen Inc's EBITDA will fall by 100.00% in the next year, reaching $16.28B. Professionals believe that By 2030, Amgen Inc's EBITDA will fall to $13.09B – a 100.00% decrease from its current value.

2023 EBITDA Forecast
$16.28B
2024 EBITDA Forecast
$16.97B
2025 EBITDA Forecast
$16.21B
2026 EBITDA Forecast
$15.23B
2027 EBITDA Forecast
$15.12B
2028 EBITDA Forecast
$15.25B
2029 EBITDA Forecast
$14.39B
2030 EBITDA Forecast
$13.09B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
XNCR Stock Forecast Xencor Buy 6
$32.92 $55.00 50.36%
CLDX Stock Forecast Celldex Therapeutics Buy 11
$44.06 $64.83 54.33%
TVTX Stock Forecast Travere Therapeutics Buy 8
$22.38 $41.00 87.67%

Amgen Inc EBIT Forecast for 2023 - 2025 - 2030

2023 EBIT Forecast
$13.01B
2024 EBIT Forecast
$13.71B
2025 EBIT Forecast
$13.77B
2026 EBIT Forecast
$13.75B
2027 EBIT Forecast
$13.89B
2028 EBIT Forecast
$13.59B
2029 EBIT Forecast
$12.89B
2030 EBIT Forecast
$12.70B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
AGIO Stock Forecast Agios Pharmaceuticals Outperform 9
$29.48 $53.75 32.29%
VCEL Stock Forecast Vericel Buy 8
$27.44 $44.60 82.22%
ENTA Stock Forecast Enanta Pharmaceuticals Outperform 10
$53.36 $90.20 25.56%

Amgen Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last zero years, Amgen Inc's EPS has fallen from $10.34 to $10.34 – a 0.00% decrease. In the next year, analysts expect EPS to reach $19.25 – an increase of 86.17%. For the next eight years, the forecast is for EPS to grow by 133.37%.

2023 EPS Forecast
$19.25
2024 EPS Forecast
$21.18
2025 EPS Forecast
$21.74
2026 EPS Forecast
$22.61
2027 EPS Forecast
$23.53
2028 EPS Forecast
$23.60
2029 EPS Forecast
$22.79
2030 EPS Forecast
$24.13
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
RVNC Stock Forecast Revance Therapeutics Outperform 6
$34.66 $38.55 -26.43%
MNKD Stock Forecast MannKind Outperform 10
$5.47 $6.50 0.55%
CERS Stock Forecast Cerus Buy 6
$3.15 $9.00 217.46%